24:@0.093275:0.957873:0.109689:0.957873:0.109689:0.938882:0.093275:0.938882:0.007823:0.008591
CHAPTER 2:@0.117647:0.067123:0.190298:0.067123:0.190298:0.047044:0.117647:0.047044:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.008197
2:@0.038824:0.247137:0.060302:0.247137:0.060302:0.199659:0.038824:0.199659:0.021478
were tested retained PAX8 and p53 expression status as observed for their correspond-:@0.117647:0.121273:0.852941:0.121273:0.852941:0.100900:0.117647:0.100900:0.014518:0.009039:0.007442:0.009039:0.004988:0.006209:0.009039:0.007510:0.006209:0.009108:0.011391:0.004988:0.007442:0.009131:0.006551:0.009085:0.005615:0.011596:0.009108:0.011391:0.004988:0.010249:0.015020:0.014107:0.010432:0.004988:0.009085:0.011596:0.011391:0.004988:0.011276:0.010432:0.010432:0.004985:0.009108:0.010089:0.011071:0.007442:0.009039:0.007533:0.007601:0.005547:0.010843:0.011756:0.004988:0.007510:0.006551:0.008811:0.006163:0.011413:0.007670:0.004988:0.009291:0.007670:0.004988:0.010957:0.010934:0.007875:0.009039:0.008400:0.009633:0.009108:0.011391:0.004988:0.006026:0.010843:0.007807:0.004988:0.006620:0.011299:0.009039:0.005615:0.007807:0.004988:0.008994:0.010843:0.007807:0.007442:0.009039:0.007510:0.011505:0.010843:0.011596:0.011391:0.007533
ing tumor tissue (:@0.117647:0.141852:0.266341:0.141852:0.266341:0.121479:0.117647:0.121479:0.005615:0.011459:0.009861:0.004543:0.006163:0.011413:0.017485:0.010843:0.007807:0.004543:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.004543:0.006939
Figure 1d,e, Extended Data Figure 2e:@0.266362:0.141852:0.595958:0.141852:0.595958:0.120719:0.266362:0.120719:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004451:0.010911:0.011687:0.005433:0.009176:0.005433:0.004546:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.004451:0.016527:0.009542:0.007053:0.009861:0.004451:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004451:0.010911:0.009473
 :@0.371635:0.141852:0.375744:0.141852:0.375744:0.121479:0.371635:0.121479:0.004109
 and :@0.595950:0.141852:0.636673:0.141852:0.636673:0.121479:0.595950:0.121479:0.004543:0.009085:0.011596:0.011391:0.004109
Supplementary Table 6:@0.637121:0.141852:0.841512:0.141852:0.841512:0.120719:0.637121:0.120719:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.004451:0.011413:0.009679:0.011528:0.005935:0.009473:0.004451:0.010911
). :@0.841505:0.141852:0.857050:0.141852:0.857050:0.121479:0.841505:0.121479:0.006939:0.004497:0.004109
Mutations in the TP53 gene can lead to diverse patterns of p53 staining, such as protein :@0.117647:0.162431:0.856940:0.162431:0.856940:0.142058:0.117647:0.142058:0.018649:0.011071:0.006551:0.008811:0.006437:0.005547:0.010843:0.011619:0.007670:0.004520:0.005615:0.011756:0.004520:0.006620:0.011302:0.009039:0.004520:0.013354:0.012167:0.010432:0.010432:0.004520:0.009656:0.009039:0.011596:0.009039:0.004520:0.009108:0.009085:0.011756:0.004520:0.005182:0.009291:0.009291:0.011391:0.004520:0.006209:0.011048:0.004520:0.011391:0.005547:0.009633:0.009039:0.007624:0.007873:0.009039:0.004520:0.011368:0.008811:0.006163:0.006209:0.009039:0.007807:0.011619:0.007670:0.004520:0.010843:0.006209:0.004520:0.011276:0.010432:0.010432:0.004520:0.007510:0.006551:0.009085:0.005615:0.011756:0.005615:0.011459:0.009679:0.004497:0.004520:0.007510:0.011347:0.008765:0.011459:0.004520:0.009291:0.007670:0.004520:0.011071:0.007442:0.010820:0.006209:0.009039:0.005615:0.011756:0.004109
loss or strong nuclear staining. Such patterns were observed in different HGS organoid :@0.117647:0.183009:0.857048:0.183009:0.857048:0.162636:0.117647:0.162636:0.005182:0.010957:0.007533:0.007670:0.005102:0.010843:0.007807:0.005102:0.007510:0.006437:0.007442:0.010843:0.011459:0.009861:0.005102:0.011391:0.011345:0.008765:0.005182:0.009291:0.009085:0.007807:0.005102:0.007510:0.006551:0.009085:0.005615:0.011756:0.005615:0.011459:0.009679:0.004497:0.005102:0.009793:0.011345:0.008765:0.011459:0.005102:0.011368:0.008811:0.006163:0.006209:0.009039:0.007807:0.011619:0.007670:0.005102:0.014518:0.009039:0.007442:0.009039:0.005100:0.010957:0.010934:0.007875:0.009039:0.008400:0.009633:0.009108:0.011391:0.005102:0.005615:0.011756:0.005100:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.005102:0.016412:0.015682:0.010112:0.005102:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.004109
lines and their corresponding tumor tissue and were in agreement with their sequencing :@0.117647:0.203588:0.857032:0.203588:0.857032:0.183215:0.117647:0.183215:0.005250:0.005615:0.011596:0.009039:0.007670:0.003835:0.009085:0.011596:0.011391:0.003835:0.006620:0.011299:0.009039:0.005615:0.007807:0.003835:0.008994:0.010843:0.007807:0.007442:0.009039:0.007510:0.011505:0.010843:0.011596:0.011391:0.005615:0.011459:0.009861:0.003835:0.006163:0.011413:0.017485:0.010843:0.007807:0.003835:0.006437:0.005615:0.007531:0.007512:0.011345:0.009039:0.003835:0.009085:0.011598:0.011391:0.003835:0.014518:0.009039:0.007442:0.009039:0.003835:0.005615:0.011756:0.003835:0.009199:0.009861:0.007442:0.009106:0.009039:0.017488:0.009039:0.011391:0.006437:0.003835:0.014723:0.005273:0.006620:0.011459:0.003835:0.006620:0.011299:0.009039:0.005615:0.007807:0.003835:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004109
data (:@0.117647:0.224167:0.166747:0.224167:0.166747:0.203794:0.117647:0.203794:0.011573:0.008811:0.006551:0.009291:0.005935:0.006939
Figure 1e:@0.166756:0.224167:0.251147:0.224167:0.251147:0.203034:0.166756:0.203034:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.005821:0.010911:0.009473
 and :@0.251137:0.224167:0.293252:0.224167:0.293252:0.203794:0.251137:0.203794:0.005935:0.009085:0.011596:0.011391:0.004109
Supplementary Table 7:@0.295097:0.224167:0.502227:0.224167:0.502227:0.203034:0.295097:0.203034:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.005821:0.011413:0.009679:0.011528:0.005935:0.009473:0.005821:0.010911
). Organoids displayed a high percentage :@0.502209:0.224167:0.857003:0.224167:0.857003:0.203794:0.502209:0.203794:0.006939:0.004497:0.005935:0.016298:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.005935:0.011391:0.005615:0.007510:0.011162:0.005433:0.008925:0.009519:0.009108:0.011391:0.005935:0.009291:0.005935:0.011459:0.005615:0.009930:0.011459:0.005935:0.011502:0.009039:0.007442:0.008994:0.009039:0.011391:0.006551:0.009199:0.009656:0.009039:0.004109
of Ki67-positive cells (:@0.117647:0.244745:0.306740:0.244745:0.306740:0.224373:0.117647:0.224373:0.010843:0.006209:0.004794:0.014472:0.005615:0.010432:0.010432:0.007533:0.011502:0.010957:0.007601:0.005273:0.006437:0.005547:0.009633:0.009039:0.004794:0.008994:0.008946:0.005387:0.005250:0.007670:0.004794:0.006939
Extended Data Figure 2b:@0.306743:0.244745:0.529347:0.244745:0.529347:0.223613:0.306743:0.223613:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.004679:0.016527:0.009542:0.007053:0.009861:0.004679:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004679:0.010911:0.011619
). Thus, histological analysis of OC or-:@0.529371:0.244745:0.852941:0.244745:0.852941:0.224373:0.529371:0.224373:0.006939:0.004497:0.004794:0.011470:0.011105:0.011413:0.007670:0.004497:0.004794:0.011459:0.005615:0.007510:0.006209:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.004794:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004794:0.010843:0.006209:0.004794:0.016778:0.014678:0.004794:0.010843:0.007237:0.007533
ganoids demonstrated their similarity to the carcinoma fields within the corresponding :@0.117647:0.265324:0.857075:0.265324:0.857075:0.244951:0.117647:0.244951:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.004634:0.011322:0.009039:0.017485:0.010843:0.011619:0.007510:0.006437:0.007898:0.008811:0.006209:0.009108:0.011391:0.004634:0.006620:0.011299:0.009039:0.005615:0.007807:0.004634:0.007601:0.005615:0.017645:0.005752:0.005433:0.009085:0.007807:0.005273:0.006437:0.009724:0.004634:0.006209:0.011048:0.004634:0.006620:0.011299:0.009039:0.004634:0.009108:0.009085:0.007442:0.008994:0.005615:0.011596:0.010843:0.017577:0.009291:0.004634:0.005684:0.005615:0.008948:0.005182:0.011391:0.007670:0.004634:0.014723:0.005273:0.006617:0.011459:0.005615:0.011756:0.004634:0.006620:0.011299:0.009039:0.004634:0.008994:0.010843:0.007807:0.007442:0.009039:0.007512:0.011502:0.010843:0.011598:0.011391:0.005615:0.011459:0.009861:0.004109
primary tumors and their distinction from non-malignant FT and OSE organoids. :@0.117647:0.285903:0.811944:0.285903:0.811944:0.265530:0.117647:0.265530:0.011071:0.007807:0.005615:0.017577:0.009085:0.008400:0.009724:0.004109:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.004109:0.009085:0.011596:0.011391:0.004109:0.006620:0.011299:0.009039:0.005615:0.007807:0.004109:0.011391:0.005615:0.007508:0.006437:0.005615:0.011596:0.009108:0.006437:0.005547:0.010843:0.011756:0.004109:0.006414:0.007442:0.010843:0.017645:0.004109:0.011596:0.010843:0.011756:0.007533:0.017577:0.009405:0.005250:0.005615:0.009861:0.011687:0.009085:0.011391:0.006437:0.004109:0.011276:0.013354:0.004109:0.009085:0.011596:0.011391:0.004109:0.016412:0.009770:0.012098:0.004109:0.010840:0.007624:0.009861:0.009085:0.011598:0.010843:0.005547:0.011391:0.007670:0.004497:0.004109
Organoids faithfully recapitulate OC at the genomic level:@0.117647:0.342904:0.631718:0.342904:0.631718:0.319745:0.117647:0.319745:0.011256:0.011081:0.011056:0.010558:0.011679:0.011256:0.004856:0.011231:0.010409:0.003984:0.008091:0.010558:0.004856:0.008616:0.011579:0.008840:0.011156:0.008691:0.006948:0.010060:0.003984:0.011231:0.009363:0.010907:0.010558:0.010733:0.004856:0.008616:0.011156:0.008691:0.009460:0.008616:0.009363:0.003984:0.011256:0.011007:0.003735:0.009463:0.008367:0.003984:0.008616:0.011579:0.009363:0.003984:0.011206:0.009363:0.011679:0.011256:0.014817:0.004856:0.011007:0.003984:0.008691:0.009363:0.010160:0.009363:0.008691
To further validate that OC organoids are composed of malignant cells, we performed :@0.117647:0.386445:0.856956:0.386445:0.856956:0.366072:0.117647:0.366072:0.010866:0.011048:0.005478:0.006369:0.011413:0.007967:0.006620:0.011299:0.009039:0.007807:0.005478:0.009838:0.009405:0.005250:0.005547:0.011573:0.008811:0.006209:0.009039:0.005478:0.006617:0.011391:0.008813:0.006437:0.005478:0.016778:0.014678:0.005478:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.005478:0.009085:0.007442:0.009039:0.005478:0.008994:0.010843:0.017280:0.011505:0.010957:0.007875:0.009108:0.011391:0.005478:0.010843:0.006209:0.005478:0.017577:0.009405:0.005250:0.005615:0.009861:0.011685:0.009085:0.011391:0.006437:0.005478:0.008994:0.008948:0.005387:0.005250:0.007670:0.004497:0.005478:0.014518:0.009039:0.005478:0.011502:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.004109
metaphase spread analysis. The majority of tested organoid lines were aneuploid, a :@0.117647:0.407023:0.857032:0.407023:0.857032:0.386650:0.117647:0.386650:0.017485:0.009131:0.006551:0.008811:0.011162:0.011391:0.009291:0.007875:0.009039:0.008492:0.007510:0.011071:0.007442:0.009291:0.009291:0.011391:0.008492:0.009085:0.011690:0.009402:0.005182:0.009724:0.007601:0.005615:0.007670:0.004497:0.008492:0.011470:0.011311:0.009039:0.008492:0.017577:0.008811:0.005341:0.010843:0.007807:0.005273:0.006437:0.009724:0.008492:0.010845:0.006209:0.008492:0.006209:0.009039:0.007510:0.006209:0.009108:0.011391:0.008492:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.008492:0.005250:0.005615:0.011596:0.009039:0.007670:0.008492:0.014518:0.009039:0.007442:0.009039:0.008492:0.009085:0.011596:0.009131:0.011071:0.011162:0.005182:0.010843:0.005547:0.011117:0.004497:0.008492:0.009291:0.004109
well-characterized hallmark of most solid tumors . Interestingly, in some cases, a sig-:@0.117647:0.427602:0.852941:0.427602:0.852941:0.407229:0.117647:0.407229:0.014518:0.008948:0.005387:0.005250:0.007533:0.008765:0.011391:0.009085:0.007898:0.009291:0.009108:0.006209:0.009039:0.007807:0.005615:0.008834:0.009106:0.011391:0.005547:0.011391:0.009405:0.005385:0.005250:0.017577:0.009085:0.007604:0.010523:0.005535:0.010843:0.006209:0.005535:0.017485:0.010957:0.007510:0.006437:0.005535:0.007875:0.010934:0.005250:0.005547:0.011391:0.005535:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.018237:0.004497:0.005535:0.006894:0.011391:0.006209:0.009039:0.007442:0.009039:0.007510:0.006437:0.005615:0.011459:0.009930:0.005182:0.007989:0.004497:0.005535:0.005615:0.011756:0.005547:0.007873:0.010843:0.017488:0.009039:0.005535:0.009108:0.009291:0.007875:0.009039:0.007670:0.004497:0.005535:0.009291:0.005547:0.007601:0.005615:0.009840:0.007533
234:@0.538358:0.419986:0.556603:0.419986:0.556603:0.408108:0.538358:0.408108:0.006082:0.006082:0.006082
nificant variation in average chromosome number was observed for different organoid :@0.117647:0.448181:0.857118:0.448181:0.857118:0.427808:0.117647:0.427808:0.011756:0.005615:0.005684:0.005615:0.009108:0.009085:0.011391:0.006437:0.005090:0.009838:0.009085:0.007807:0.005798:0.008811:0.006437:0.005547:0.010843:0.011756:0.005090:0.005615:0.011756:0.005090:0.008925:0.009633:0.009039:0.007898:0.009199:0.009656:0.009039:0.005090:0.008765:0.011459:0.007442:0.010843:0.017485:0.010957:0.007875:0.010843:0.017485:0.009039:0.005090:0.011391:0.011413:0.017394:0.011254:0.009039:0.007807:0.005090:0.014723:0.009291:0.007670:0.005090:0.010957:0.010934:0.007873:0.009039:0.008400:0.009633:0.009108:0.011391:0.005090:0.006026:0.010843:0.007807:0.005090:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.005090:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.004109
lines derived from the same patient (:@0.117647:0.468759:0.424140:0.468759:0.424140:0.448386:0.117647:0.448386:0.005250:0.005615:0.011596:0.009039:0.007670:0.004109:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391:0.004109:0.006412:0.007442:0.010843:0.017645:0.004109:0.006620:0.011299:0.009039:0.004109:0.007944:0.009085:0.017485:0.009039:0.004109:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.004109:0.006939
Figure 2a:@0.424140:0.468759:0.507115:0.468759:0.507115:0.447626:0.424140:0.447626:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004018:0.010911:0.009861
). :@0.507114:0.468759:0.522659:0.468759:0.522659:0.448386:0.507114:0.448386:0.006939:0.004497:0.004109
To determine whether OC organoids faithfully recapitulate the genomic landscape of :@0.117647:0.489338:0.857052:0.489338:0.857052:0.468965:0.117647:0.468965:0.010866:0.011048:0.006403:0.011322:0.009131:0.006209:0.009039:0.007807:0.017645:0.005615:0.011596:0.009039:0.006403:0.014792:0.011299:0.009131:0.006620:0.011299:0.009039:0.007807:0.006403:0.016778:0.014678:0.006403:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.006403:0.006209:0.009085:0.005273:0.006620:0.011459:0.006366:0.011550:0.005387:0.005182:0.009724:0.006403:0.007442:0.009108:0.009108:0.008811:0.011071:0.005273:0.006163:0.011550:0.005433:0.008811:0.006209:0.009039:0.006403:0.006620:0.011299:0.009039:0.006403:0.009656:0.009039:0.011596:0.010845:0.017645:0.005547:0.008994:0.006403:0.005433:0.009085:0.011598:0.011391:0.007873:0.009108:0.008811:0.011505:0.009039:0.006403:0.010843:0.006209:0.004109
the primary tumors from which they were derived, we next performed whole-genome :@0.117647:0.509917:0.857144:0.509917:0.857144:0.489544:0.117647:0.489544:0.006620:0.011299:0.009039:0.005478:0.011071:0.007807:0.005615:0.017577:0.009085:0.008400:0.009724:0.005478:0.006166:0.011413:0.017485:0.010843:0.007624:0.007670:0.005478:0.006414:0.007442:0.010843:0.017645:0.005478:0.014792:0.011459:0.005547:0.008765:0.011459:0.005478:0.006620:0.011299:0.009334:0.009724:0.005478:0.014518:0.009039:0.007442:0.009039:0.005478:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011117:0.004497:0.005478:0.014518:0.009039:0.005478:0.011596:0.009108:0.010089:0.006437:0.005478:0.011505:0.009039:0.007807:0.006026:0.010843:0.007807:0.017485:0.009108:0.011391:0.005478:0.014792:0.011299:0.010934:0.005182:0.009039:0.007533:0.009656:0.009039:0.011596:0.010843:0.017485:0.009039:0.004109
sequencing (WGS) analysis. In total, we sequenced 40 organoid lines from 22 different :@0.117647:0.530495:0.857134:0.530495:0.857134:0.510123:0.117647:0.510123:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.005296:0.006825:0.020270:0.015682:0.010112:0.006939:0.005284:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004497:0.005296:0.006894:0.011756:0.005296:0.006209:0.010820:0.006551:0.009405:0.004976:0.004497:0.005296:0.014518:0.009039:0.005284:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.009108:0.011391:0.005296:0.010432:0.010432:0.005296:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.005296:0.005250:0.005615:0.011598:0.009039:0.007670:0.005284:0.006414:0.007442:0.010843:0.017645:0.005296:0.010432:0.010432:0.005296:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.004109
patients. The corresponding tumor and normal blood samples for 35 of these lines were :@0.117647:0.551074:0.856984:0.551074:0.856984:0.530701:0.117647:0.530701:0.011368:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.007670:0.004497:0.004383:0.011470:0.011311:0.009039:0.004383:0.008994:0.010843:0.007807:0.007442:0.009039:0.007512:0.011502:0.010843:0.011598:0.011391:0.005615:0.011457:0.009861:0.004383:0.006163:0.011413:0.017485:0.010843:0.007807:0.004383:0.009085:0.011598:0.011391:0.004383:0.011596:0.010843:0.007807:0.017577:0.009405:0.005250:0.004383:0.010911:0.005182:0.011276:0.011276:0.011391:0.004383:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004383:0.006024:0.010843:0.007807:0.004383:0.010432:0.010432:0.004383:0.010843:0.006209:0.004383:0.006620:0.011299:0.009039:0.007875:0.009039:0.004383:0.005250:0.005615:0.011596:0.009039:0.007670:0.004383:0.014518:0.009039:0.007442:0.009039:0.004109
also sequenced and used as a reference (:@0.117647:0.571653:0.464397:0.571653:0.464397:0.551280:0.117647:0.551280:0.009405:0.005250:0.007875:0.011048:0.005901:0.007875:0.009108:0.010703:0.011347:0.009039:0.011596:0.008994:0.009108:0.011391:0.005898:0.009087:0.011596:0.011391:0.005901:0.011413:0.007875:0.009108:0.011391:0.005901:0.009291:0.007670:0.005901:0.009291:0.005901:0.007442:0.009039:0.006026:0.009039:0.007442:0.009039:0.011596:0.008994:0.009039:0.005901:0.006939
Supplementary Table 7:@0.464396:0.571653:0.671435:0.571653:0.671435:0.550520:0.464396:0.550520:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.005775:0.011413:0.009679:0.011528:0.005935:0.009473:0.005775:0.010911
). We first used WGS :@0.671423:0.571653:0.857050:0.571653:0.857050:0.551280:0.671423:0.551280:0.006939:0.004497:0.005901:0.018649:0.009039:0.005901:0.005684:0.005684:0.007624:0.007510:0.006437:0.005901:0.011413:0.007875:0.009108:0.011391:0.005901:0.020270:0.015682:0.010112:0.004109
data to estimate the percentage of malignant cells in both organoid and tumor samples . :@0.117647:0.592232:0.857050:0.592232:0.857050:0.571859:0.117647:0.571859:0.011573:0.008811:0.006551:0.009291:0.003766:0.006209:0.011048:0.003766:0.009039:0.007512:0.006437:0.005615:0.017577:0.008809:0.006211:0.009039:0.003766:0.006620:0.011299:0.009039:0.003766:0.011505:0.009039:0.007442:0.008994:0.009039:0.011391:0.006551:0.009199:0.009656:0.009039:0.003766:0.010843:0.006209:0.003766:0.017577:0.009405:0.005250:0.005615:0.009861:0.011687:0.009085:0.011391:0.006437:0.003766:0.008994:0.008948:0.005387:0.005250:0.007670:0.003766:0.005615:0.011756:0.003766:0.011251:0.010820:0.006620:0.011459:0.003766:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.003766:0.009085:0.011598:0.011391:0.003766:0.006163:0.011413:0.017485:0.010843:0.007807:0.003766:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.012230:0.004497:0.004109
29:@0.836281:0.584616:0.848445:0.584616:0.848445:0.572738:0.836281:0.572738:0.006082:0.006082
As predicted from histological analysis, in most cases, cancer cell content of organoids :@0.117647:0.612810:0.857048:0.612810:0.857048:0.592437:0.117647:0.592437:0.014586:0.007670:0.005456:0.011071:0.007442:0.009108:0.011391:0.005547:0.009108:0.006209:0.009106:0.011391:0.005456:0.006414:0.007442:0.010843:0.017645:0.005456:0.011459:0.005615:0.007510:0.006209:0.010934:0.005182:0.011048:0.009861:0.005547:0.009108:0.009405:0.005250:0.005456:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004497:0.005456:0.005615:0.011756:0.005456:0.017485:0.010957:0.007510:0.006437:0.005456:0.009106:0.009291:0.007875:0.009039:0.007670:0.004497:0.005456:0.009108:0.009085:0.011596:0.008994:0.009039:0.007807:0.005456:0.008994:0.008948:0.005387:0.005250:0.005456:0.008994:0.010843:0.011391:0.006209:0.009039:0.011391:0.006437:0.005456:0.010843:0.006209:0.005456:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.004109
was considerably higher than that of the corresponding tumor (tumor organoids 88.1 :@0.117647:0.633389:0.857052:0.633389:0.857052:0.613016:0.117647:0.613016:0.014723:0.009291:0.007670:0.006003:0.008994:0.010843:0.011619:0.007601:0.005547:0.011322:0.009039:0.007898:0.009108:0.010911:0.005182:0.009724:0.006003:0.011459:0.005615:0.009930:0.011299:0.009039:0.007807:0.006003:0.006620:0.011391:0.009085:0.011756:0.006003:0.006620:0.011391:0.008811:0.006437:0.006003:0.010843:0.006209:0.006003:0.006620:0.011299:0.009039:0.006003:0.008994:0.010843:0.007807:0.007442:0.009039:0.007510:0.011505:0.010843:0.011596:0.011391:0.005615:0.011459:0.009861:0.006003:0.006163:0.011413:0.017485:0.010843:0.007807:0.006003:0.006939:0.006163:0.011413:0.017485:0.010843:0.007807:0.006003:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.006003:0.010432:0.010432:0.004497:0.010432:0.004109
± 23% versus tumor tissue 45.1 ± 9.2% (mean ± s.d.) across all samples; :@0.117647:0.653968:0.719544:0.653968:0.719544:0.633595:0.117647:0.633595:0.011779:0.004862:0.010432:0.010432:0.015043:0.004862:0.009633:0.009039:0.007624:0.007510:0.011413:0.007670:0.004862:0.006166:0.011413:0.017485:0.010843:0.007807:0.004862:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.004862:0.010432:0.010432:0.004497:0.010432:0.004862:0.011779:0.004862:0.010432:0.004497:0.010432:0.015043:0.004862:0.006939:0.017485:0.009288:0.009085:0.011756:0.004862:0.011779:0.004862:0.007670:0.004497:0.011117:0.004497:0.006939:0.004862:0.009291:0.008994:0.007442:0.010957:0.007533:0.007670:0.004862:0.009405:0.005387:0.005250:0.004862:0.007944:0.009085:0.017280:0.011162:0.005182:0.009039:0.007670:0.004497:0.004109
Extended Data :@0.720333:0.653968:0.856949:0.653968:0.856949:0.632835:0.720333:0.632835:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.004748:0.016527:0.009542:0.007053:0.009861:0.004018
Figure 2d:@0.117647:0.674546:0.201627:0.674546:0.201627:0.653413:0.117647:0.653413:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.003013:0.010911:0.011870
 and :@0.201628:0.674546:0.240890:0.674546:0.240890:0.654173:0.201628:0.654173:0.003082:0.009085:0.011596:0.011391:0.004109
Supplementary Table 7:@0.239868:0.674546:0.441383:0.674546:0.441383:0.653413:0.239868:0.653413:0.010455:0.011893:0.011733:0.011779:0.005935:0.009268:0.018102:0.009268:0.012053:0.007053:0.009656:0.009359:0.009998:0.003013:0.011413:0.009679:0.011528:0.005935:0.009473:0.003013:0.010911
). CNV analysis revealed similar patterns between :@0.441386:0.674546:0.857035:0.674546:0.857035:0.654173:0.441386:0.654173:0.006939:0.004497:0.003082:0.014678:0.016230:0.015089:0.003082:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.003082:0.007442:0.009336:0.009633:0.009291:0.009402:0.005182:0.009108:0.011391:0.003082:0.007601:0.005615:0.017645:0.005752:0.005433:0.009085:0.007807:0.003082:0.011368:0.008811:0.006163:0.006209:0.009039:0.007807:0.011619:0.007670:0.003082:0.011254:0.009131:0.006437:0.014518:0.009106:0.009039:0.011756:0.004109
organoid/tumor pairs (:@0.117647:0.695125:0.311526:0.695125:0.311526:0.674752:0.117647:0.674752:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007099:0.006163:0.011413:0.017485:0.010843:0.007807:0.003995:0.011365:0.009087:0.005615:0.007624:0.007670:0.003983:0.006939
Figure 2b :@0.311517:0.695125:0.400153:0.695125:0.400153:0.673992:0.311517:0.673992:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.003903:0.010911:0.011619:0.004018
and :@0.400023:0.695125:0.436203:0.695125:0.436203:0.674752:0.400023:0.674752:0.009085:0.011596:0.011391:0.004109
Extended Data Figure 4a:@0.436079:0.695125:0.654598:0.695125:0.654598:0.673992:0.436079:0.673992:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.003903:0.016527:0.009542:0.007053:0.009861:0.003903:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.003903:0.010911:0.009861
). Moreover, comparing :@0.654575:0.695125:0.857060:0.695125:0.857060:0.674752:0.654575:0.674752:0.006939:0.004497:0.003983:0.018969:0.010843:0.007442:0.009108:0.010866:0.009633:0.009039:0.006255:0.004497:0.003995:0.008994:0.010843:0.017280:0.011368:0.009085:0.007807:0.005615:0.011459:0.009861:0.004109
the genomic landscape from early and late passage HGS organoids revealed that CNVs :@0.117647:0.715704:0.857146:0.715704:0.857146:0.695331:0.117647:0.695331:0.006620:0.011299:0.009039:0.004839:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.004839:0.005433:0.009085:0.011598:0.011391:0.007873:0.009108:0.008811:0.011505:0.009039:0.004839:0.006414:0.007442:0.010843:0.017645:0.004839:0.009291:0.009085:0.007601:0.005182:0.009724:0.004839:0.009085:0.011596:0.011391:0.004839:0.005433:0.008811:0.006209:0.009039:0.004839:0.011368:0.009291:0.007533:0.007944:0.009199:0.009656:0.009039:0.004839:0.016412:0.015682:0.010112:0.004839:0.010845:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.004839:0.007442:0.009336:0.009633:0.009291:0.009405:0.005182:0.009108:0.011391:0.004839:0.006620:0.011391:0.008811:0.006437:0.004839:0.014678:0.016230:0.015089:0.007670:0.004109
were well maintained even after prolonged passaging (HGS-1, passage eight versus 32; :@0.117647:0.736282:0.857002:0.736282:0.857002:0.715910:0.117647:0.715910:0.014518:0.009039:0.007442:0.009039:0.005547:0.014518:0.008948:0.005387:0.005250:0.005547:0.017577:0.009085:0.005615:0.011391:0.006551:0.009085:0.005615:0.011596:0.009108:0.011391:0.005547:0.009336:0.009633:0.009039:0.011756:0.005547:0.009085:0.006197:0.005969:0.009039:0.007807:0.005547:0.011071:0.007442:0.010934:0.005182:0.010843:0.011459:0.009656:0.009108:0.011391:0.005547:0.011368:0.009291:0.007533:0.007944:0.009199:0.009861:0.005615:0.011459:0.009861:0.005547:0.006939:0.016410:0.015682:0.010112:0.007533:0.010432:0.004497:0.005547:0.011365:0.009291:0.007533:0.007944:0.009199:0.009656:0.009039:0.005547:0.009039:0.005615:0.009930:0.011094:0.006437:0.005547:0.009633:0.009039:0.007624:0.007510:0.011413:0.007670:0.005547:0.010432:0.010432:0.004497:0.004109
HGS-2, passage six versus 15; HGS-3.1, passage four versus 32; HGS-3.2, passage four :@0.117647:0.756861:0.857023:0.756861:0.857023:0.736488:0.117647:0.736488:0.016412:0.015682:0.010112:0.007533:0.010432:0.004497:0.005615:0.011368:0.009291:0.007531:0.007944:0.009199:0.009656:0.009039:0.005615:0.007601:0.005615:0.010089:0.005615:0.009635:0.009039:0.007622:0.007512:0.011413:0.007670:0.005615:0.010432:0.010432:0.004497:0.005615:0.016412:0.015682:0.010112:0.007533:0.010432:0.004497:0.010432:0.004497:0.005615:0.011365:0.009291:0.007533:0.007944:0.009199:0.009656:0.009039:0.005615:0.006024:0.010820:0.011413:0.007807:0.005615:0.009633:0.009039:0.007624:0.007510:0.011413:0.007670:0.005615:0.010432:0.010432:0.004497:0.005615:0.016412:0.015682:0.010112:0.007533:0.010432:0.004497:0.010432:0.004497:0.005615:0.011368:0.009291:0.007533:0.007941:0.009201:0.009653:0.009039:0.005615:0.006026:0.010820:0.011413:0.007807:0.004109
versus 25; HGS-6, passage eight versus 21; HGS-1-R2, passage four versus 17; :@0.117647:0.777440:0.770379:0.777440:0.770379:0.757067:0.117647:0.757067:0.009633:0.009039:0.007624:0.007510:0.011413:0.007670:0.004269:0.010432:0.010432:0.004497:0.004269:0.016412:0.015682:0.010112:0.007533:0.010432:0.004497:0.004269:0.011368:0.009291:0.007533:0.007944:0.009199:0.009656:0.009039:0.004269:0.009039:0.005615:0.009927:0.011094:0.006437:0.004269:0.009635:0.009039:0.007622:0.007512:0.011413:0.007670:0.004269:0.010432:0.010432:0.004497:0.004269:0.016412:0.015682:0.010112:0.007533:0.010432:0.007533:0.013376:0.010432:0.004497:0.004269:0.011368:0.009291:0.007533:0.007944:0.009199:0.009656:0.009039:0.004269:0.006026:0.010820:0.011413:0.007807:0.004269:0.009633:0.009039:0.007624:0.007510:0.011413:0.007670:0.004269:0.010432:0.010432:0.004497:0.004109
Figure 2c:@0.770476:0.777440:0.852950:0.777440:0.852950:0.756307:0.770476:0.756307:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004177:0.010911:0.009199
 :@0.852941:0.777440:0.857050:0.777440:0.857050:0.757067:0.852941:0.757067:0.004109
and :@0.117647:0.798019:0.153827:0.798019:0.153827:0.777646:0.117647:0.777646:0.009085:0.011596:0.011391:0.004109
Extended Data Figure 4a:@0.155847:0.798019:0.380629:0.798019:0.380629:0.776886:0.155847:0.776886:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.005992:0.016527:0.009542:0.007053:0.009861:0.005992:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.005990:0.010911:0.009861
). Most organoids derived from HGS tumors displayed :@0.380630:0.798019:0.857050:0.798019:0.857050:0.777646:0.380630:0.777646:0.006939:0.004497:0.006127:0.018969:0.010957:0.007510:0.006437:0.006129:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.006127:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391:0.006127:0.006414:0.007442:0.010843:0.017645:0.006129:0.016412:0.015682:0.010112:0.006127:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.006129:0.011391:0.005615:0.007510:0.011162:0.005433:0.008925:0.009519:0.009108:0.011391:0.004109
many CNVs, whereas organoids derived from type I tumors and BTs revealed a relatively :@0.117647:0.818597:0.857050:0.818597:0.857050:0.798224:0.117647:0.798224:0.017577:0.009085:0.011368:0.009724:0.003504:0.014678:0.016230:0.015089:0.007670:0.004497:0.003502:0.014792:0.011299:0.009039:0.007442:0.009291:0.009291:0.007670:0.003502:0.010845:0.007624:0.009861:0.009083:0.011598:0.010843:0.005547:0.011391:0.007670:0.003502:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391:0.003504:0.006412:0.007442:0.010843:0.017645:0.003504:0.006437:0.009724:0.011505:0.009039:0.003502:0.007259:0.003504:0.006163:0.011413:0.017485:0.010843:0.007624:0.007670:0.003504:0.009085:0.011596:0.011391:0.003504:0.012395:0.010888:0.007670:0.003502:0.007442:0.009336:0.009633:0.009291:0.009405:0.005182:0.009108:0.011391:0.003502:0.009291:0.003504:0.007442:0.008948:0.005433:0.008811:0.006437:0.005547:0.009633:0.008948:0.005182:0.009724:0.004109
subtle number of CNVs (:@0.117647:0.839176:0.333086:0.839176:0.333086:0.818803:0.117647:0.818803:0.007510:0.011345:0.010797:0.006620:0.005182:0.009039:0.004748:0.011391:0.011413:0.017394:0.011254:0.009039:0.007807:0.004748:0.010843:0.006209:0.004748:0.014678:0.016230:0.015089:0.007670:0.004748:0.006939
Figure 2b:@0.333099:0.839176:0.418460:0.839176:0.418460:0.818043:0.333099:0.818043:0.011596:0.006209:0.010751:0.011893:0.008263:0.009473:0.004645:0.010911:0.011619
 and :@0.418460:0.839176:0.459388:0.839176:0.459388:0.818803:0.418460:0.818803:0.004748:0.009085:0.011596:0.011391:0.004109
Extended Data 4a:@0.460035:0.839176:0.617959:0.839176:0.617959:0.818043:0.460035:0.818043:0.012692:0.010318:0.006871:0.009268:0.012167:0.011961:0.009722:0.011870:0.004657:0.016527:0.009539:0.007056:0.009861:0.004645:0.010911:0.009861
). Thus, OC organoids reca-:@0.617950:0.839176:0.852941:0.839176:0.852941:0.818803:0.617950:0.818803:0.006939:0.004497:0.004748:0.011470:0.011105:0.011413:0.007670:0.004497:0.004748:0.016778:0.014678:0.004748:0.010843:0.007624:0.009861:0.009085:0.011596:0.010843:0.005547:0.011391:0.007670:0.004748:0.007442:0.009108:0.009108:0.009303:0.007533
pitulate the genomic characteristics of the different OC subtypes from which they are :@0.117647:0.859755:0.857052:0.859755:0.857052:0.839382:0.117647:0.839382:0.011071:0.005273:0.006163:0.011550:0.005433:0.008811:0.006209:0.009039:0.006049:0.006620:0.011299:0.009039:0.006049:0.009656:0.009039:0.011596:0.010843:0.017645:0.005547:0.008994:0.006049:0.008765:0.011391:0.009085:0.007898:0.009291:0.009108:0.006209:0.009039:0.007807:0.005615:0.007510:0.006437:0.005547:0.008994:0.007670:0.006049:0.010840:0.006209:0.006049:0.006620:0.011302:0.009039:0.006049:0.011391:0.005615:0.005969:0.005787:0.009039:0.007442:0.009039:0.011391:0.006437:0.006049:0.016778:0.014678:0.006049:0.007510:0.011345:0.010797:0.006437:0.009724:0.011505:0.009039:0.007670:0.006049:0.006412:0.007442:0.010845:0.017645:0.006049:0.014792:0.011459:0.005547:0.008765:0.011459:0.006049:0.006620:0.011299:0.009336:0.009724:0.006049:0.009085:0.007442:0.009039:0.004109
derived:@0.117647:0.880334:0.181493:0.880334:0.181493:0.859961:0.117647:0.859961:0.011322:0.009039:0.007807:0.005547:0.009633:0.009108:0.011391
216,235:@0.181493:0.872717:0.220605:0.872717:0.220605:0.860840:0.181493:0.860840:0.006082:0.006082:0.006082:0.002622:0.006082:0.006082:0.006082
.:@0.220604:0.880334:0.225101:0.880334:0.225101:0.859961:0.220604:0.859961:0.004497
 :@0.481559:0.900912:0.485668:0.900912:0.485668:0.880539:0.481559:0.880539:0.004109